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in numerous organs and their shortened lifespan. Ercc1−/Δ mice display combined 
features	of	human	progeroid	and	cancer-prone	syndromes.	Although	several	stud-
ies report cellular senescence and apoptosis associated with the premature aging of 
Ercc1−/Δ	mice,	the	link	between	these	two	processes	and	their	physiological	relevance	













stem cell depletion through apoptosis promoted by senescent cells.
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the	hallmarks	of	 aging	 (Hasty,	Campisi,	Hoeijmakers,	 van	Steeg,	&	
Vijg,	2003).	The	major	defenses	against	the	genotoxic	and	cytotoxic	
consequences	of	DNA	damage	are	two	cell	fates:	cellular	senescence	
and apoptosis. To prevent the propagation of damaged or dysfunc-
tional	 cells,	 senescence	 arrests	 proliferation,	 essentially	 irrevers-
ibly,	but	senescent	cells	remain	viable	and	metabolically	active.	By	
contrast,	apoptosis	 is	a	 form	of	programmed	cell	death	and	there-
fore effectively eliminates damaged or dysfunctional cells. Despite 
being	distinct	cell	fates	with	different	outcomes,	both	can	be	ben-









foster	 chronic	 inflammation,	 modify	 tissue	 microenvironments,	
and alter the functions of neighboring cells—all owing to the se-
cretion	 of	 numerous	 factors,	 including	 pro-inflammatory	 cyto-
kines,	 chemokines,	 growth	 factors,	 and	 proteases,	 termed	 the	
senescence-associated	 secretory	 phenotype	 (SASP)	 (Campisi,	
2013;	 Coppe	 et	 al.,	 2010,	 2008;	 Davalos	 et	 al.,	 2013;	 Kuilman,	
Michaloglou,	 Mooi,	 &	 Peeper,	 2010).	 Using	 transgenic	 mice	 in	
which	senescent	cells	can	be	selectively	eliminated,	both	lifelong	
and	late-life	clearance	were	shown	to	extend	median	lifespan	and	
attenuate	 several	 deleterious	 age-associated	 phenotypes;	 these	
benefits were apparent in both progeric and naturally aged mice 
(Baker	et	al.,	2011).	Thus,	cellular	senescence	has	emerged	as	an	
important causative driver of many aging phenotypes and pa-
thologies.	Likewise,	many	aging	phenotypes	and	pathologies	can	





including the ability to suppress tumorigenesis and potential to con-
tribute	to	aging	and	age-associated	diseases.	They	also	share	certain	
regulatory	axes,	such	as	control	by	the	p53-p21	and	PTEN-PI3K-Akt	
pathways	 (Childs	 et	 al.,	 2014).	Depending	on	 the	degree	of	 stress	
and	type	of	DNA	damage,	as	well	as	the	cell	type,	state,	and	history,	
cells	 may	 undergo	 either	 senescence	 or	 apoptosis.	 Interestingly,	
senescent	 cells	 are	 generally	 resistant	 to	 apoptosis	 (Childs	 et	 al.,	
2014;	Yosef	et	al.,	2016).	Nonetheless,	 senescent	endothelial	 cells	
can	 become	 susceptible	 to	 apoptosis	 upon	 reduced	 BCL-2	 or	 in-
creased	BAX	expression	 (Zhang,	Patel,	&	Block,	2002)	or	 reduced	
nitric	 oxide	 synthase	 (eNOS)	 (Li,	 Guo,	Dressman,	 Asmis,	 &	 Smart,	




repair	protein	 that	 forms	a	heterodimer	with	XPF	 (xeroderma	pig-
mentosum	group	F-complementing	protein,	also	known	as	ERCC4)	
and	 functions	 as	 a	 5′-3′	 structure-specific	 endonuclease.	 It	 par-
ticipates	 in	 a	 number	of	DNA	 repair	 pathways	 in	mammalian	 cells	
(Dolle	et	al.,	2011;	Weeda	et	al.,	1997).	The	heterodimer	is	required	
for	incising	the	damaged	strand	of	DNA	during	nucleotide	excision	







distinct syndromes. These syndromes include Cockayne and cere-
bro-oculo-facial-skeletal	(COFS)	syndromes	characterized	by	severe	
progressive developmental deficiencies and neurological abnormali-
ties,	as	well	as	many	other	aging	phenotypes	and	an	extremely	short	
lifespan	 (Gregg,	 Robinson,	 &	 Niedernhofer,	 2011;	 Jaspers	 et	 al.,	
2007;	Niedernhofer	et	al.,	2006).	They	also	include	the	cancer-prone	
disorders	 xeroderma	pigmentosum,	Fanconi	 anemia,	 and	XFE	 syn-
drome	(Marteijn	et	al.,	2014).	An	important	tool	for	studying	these	
diverse syndromes is Ercc1−/Δ mice. These mice lack one functional 
Ercc1	allele	and	are	hemizygous	for	a	single	truncated	allele	encod-
ing a hypomorphic Ercc1 variant that lacks the last seven amino 






although in their short lifespan they do not develop overt neoplastic 
lesions	(Vermeij,	Hoeijmakers,	&	Pothof,	2016).	Several	groups	have	
described the presence of senescent cells in Ercc1−/Δ mice and sug-
gested a role for these cells in accelerating aging phenotypes and 
pathologies	when	there	is	a	defect	in	DNA	damage	repair	(Robinson	
et	al.,	2018;	Tilstra	et	al.,	2012;	Weeda	et	al.,	1997).	Concomitantly,	
apoptosis and its link to tissue atrophy and pathologies in the 
Ercc1−/Δ mice have been observed by other groups (Niedernhofer et 
al.,	2006;	Takayama	et	al.,	2014).	It	is	unclear	whether	and	how	these	
two	distinct	cell	fates	are	linked	in	this	DNA	damage-driven,	prema-
ture aging mouse model.
Here,	we	show	that	DNA	damage	driven	by	deficient	ERCC1	ex-
pression or activity promotes cellular senescence in human cells in 






senescent cells promoted apoptosis in neighboring nonsenescent 
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cells	 as	 well	 as	 senescent	 cells	 themselves.	We	 confirmed	 an	 in-




we	 determined	 that	 the	 SASP	 factor	 TNFα accelerated apoptosis 
in	ERCC1-depleted	cells,	which	likely	contributes	to	the	premature	
aging phenotypes and tissue dysfunction in Ercc1−/Δ mice.
2  | RESULTS
2.1 | ERCC1 deficiency promotes cellular 
senescence in skin
To	examine	the	accumulation	of	cellular	senescence	in	progressively	
aged Ercc1−/Δ mice in vivo,	we	compared	skin	tissues	of	Ercc1−/Δ ani-
mals	with	age-matched	littermates	and	older	wild-type	(wt)	control	
mice.	SA-β-gal	staining	showed	that	the	presence	of	senescent	cells	
in Ercc1−/Δ	 skin	 increased	progressively	 from	4	to	18	weeks	of	age	




Ercc1−/Δ	mice.	Histological	 examination	 of	 the	 skin	 from	 18-week-
old skin of Ercc1−/Δ mutants showed typical signs of aging such as 
hyperplasia	of	the	epidermis	and	atrophy	of	the	dermis	(Figure	1a),	
possibly due to loss and degeneration of the elastic fiber network.
Senescent	 cells	 undergo	 nuclear	 reorganization,	 accompanied	
by	 a	 reduction	 in	 lamin	 B1	 (LMNB1)	 mRNA	 and	 protein	 (Freund,	
Laberge,	Demaria,	&	Campisi,	2012).	 Immunofluorescence	staining	








To determine whether there is a direct role for ERCC1 defi-
ciency	in	inducing	senescence,	we	used	lentiviruses	and	two	primary	
human	fibroblast	strains,	HCA2	and	 IMR-90,	 to	express	 two	 inde-
pendent	short	hairpin	RNAs	(shRNAs)	against	ERCC1	(shERCC1	#1	









(IL1α,	 IL6,	 TNFα)	 and	matrix	metalloproteinase	 (MMP3),	 increased	
significantly	 upon	ERCC1	depletion	 (Figure	 2d,	 right	 panel;	 Figure	
S1B,	 right	 panel).	 Immunofluorescence	 staining	 confirmed	 that	
ERCC1	depletion	resulted	in	a	loss	of	LMNB1	expression	(Figure	2e	
and	Figure	S1D),	loss	of	nuclear	HMGB1	(Figure	2f	and	Figure	S1E),	
and an increase in γH2AX	foci	(Figure	2g	and	Figure	S1F),	all	of	which	
can	also	serve	as	senescence	markers	(Davalos	et	al.,	2013;	Rodier	
et	 al.,	 2009).	 ERCC1	 depletion	 using	 siRNA	 further	 validated	 the	
increased	 number	 of	 SA-β-gal-positive	 cells,	 as	well	 as	 changes	 in	
expression	of	the	senescence	markers	measured	after	shRNA	deple-
tion	(Figure	2h-I).
2.2 | Cellular senescence induced by ERCC1 
deficiency is p53-dependent
To determine whether cellular senescence induced by ERCC1 de-
ficiency	 is	 p53-dependent,	 we	 used	 lentivirus-mediated	 shRNA	
depletion of p53 in fibroblasts in which ERCC1 was subsequently 
depleted.	The	increased	number	of	SA-β-gal-positive	cells	normally	




mRNA	 levels	 (Figure	 3b).	 However,	 the	 expression	 of	 SASP	 com-
ponents	 (IL1α,	 IL6,	and	TNFα	mRNAs)	was	enhanced	upon	double	
knockdown of p53/ERCC1 compared to a single knockdown of 
ERCC1	 (Figure	 3c),	 consistent	with	 the	 negative	 regulation	 of	 the	
SASP	by	p53,	as	reported	(Coppe	et	al.,	2008;	Rodier	et	al.,	2009).	
These results indicate that the senescence induced by ERCC1 defi-
ciency	is	p53-dependent	and	confirm	that	p53	restrains	SASP	factor	
expression.
2.3 | TNFα secreted by senescent cells 
promotes apoptosis
Our	findings	suggested	that	senescent	cells	might	play	a	causal	role	
in	the	age-related	phenotypes	of	Ercc1−/Δ mice. To test this possibil-
ity,	we	bred	Ercc1−/Δ	mice	with	p16-3MR	mice	and	senescent	cells	
were eliminated by treatment with ganciclovir. Eliminating senes-
cent	cells	neither	rescued	obvious	aging	phenotypes	nor	extended	
lifespan	 (Figure	 S2A),	 suggesting	 that	 other	mechanisms	drive	 the	
phenotypes	resulting	from	Ercc1	deficiency.	Indeed,	we	found	that	
ERCC1 deficiency in human fibroblasts not only induced cellular 






depletion,	 these	 two	distinct	 cellular	processes	appeared	 to	 coex-
ist.	To	understand	how	these	two	processes	were	related,	we	per-
formed	SA-β-gal	staining	followed	by	immunofluorescence	staining	
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for	 cleaved	 caspase	 3	 (Figure	 4b).	 About	 10%	 of	 the	 cells	 co-ex-
pressed	SA-β-gal	and	cleaved	caspase	3,	suggesting	that	senescence	
and	 apoptosis	 were	 concomitant	 in	 a	 fraction	 of	 ERCC1-deficient	
fibroblasts.	However,	20%–25%	of	ERCC1-deficient	fibroblasts	that	
were	not	SA-β-gal	positive	also	underwent	apoptosis.	These	findings	









deficient fibroblasts was significantly higher than control fibroblasts 
(Figure	4c).	TNFα	was	shown	to	 impede	the	repair	of	certain	DNA	
F I G U R E  1  Accumulation	of	senescent	cells	in	the	skin	of	Ercc1−/Δ	mice.	(a)	Ercc1−/Δ	and	wild-type	(wt)	mouse	skin	at	the	indicated	
ages	were	stained	for	senescence-associated	β-galactosidase	(SA-β-gal,	blue)	activity	and	counterstained	with	nuclear	fast	red	(red).	
Representative	images	(left	panel)	and	quantification	(right	panel)	are	shown.	N = 2–4 animals per condition. Each dot in the graph 
corresponds to skin from a different animal. Data are mean ± SEM,	two-tailed	Welch's	adjusted	t-test.	(b,	c)	Representative	images	of	
immunofluorescence	staining	for	lamin	B1	(LMNB1)	(b)	and	Ki67	(c)	performed	on	Ercc1−/Δ and wt skin tissue from mice of the indicated 
genotype	and	age	(w	=	weeks).	DAPI	was	used	for	counterstaining.	Representative	images	are	shown,	and	n = 3 tissues were evaluated per 
condition. p-value:	*p	<	.05,	**p	<	.01,	***p < .001
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percent cells with at least two γH2AX	foci	(g),	were	determined	in	the	three	cell	populations	by	immunofluorescence.	A	representative	




markers. β-actin	was	used	for	normalization.	n	=	2,	two-tailed	Welch's	adjusted	t-test.	p-value:	*p	<	.05,	**p	<	.01,	***p < .001
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lesions,	such	as	cyclobutane	pyrimidine	dimers,	and	increase	apop-
tosis	 in	 NER-incompetent	 cells	 via	 replication	 stress	 (Faurschou,	
Gniadecki,	 Calay,	 &	Wulf,	 2008).	We	 therefore	 hypothesized	 that	
ERCC1-deficient	 cells	would	 be	 susceptible	 to	 apoptosis	 owing	 to	
TNFα	secretion	by	senescent	cells.	To	test	this	hypothesis,	we	dis-
abled	 TNFα	 activity	 in	 conditioned	 media	 from	 ERCC1-deficient	
cells	using	a	blocking	antibody,	or	blocked	TNFα	signaling	in	ERCC1-





was	 significantly	 diminished	 by	 treatment	 with	 either	 the	 TNFα-
blocking	antibody	or	SPD304,	as	well	as	an	 inhibitor	of	caspase	8,	
Z-IETD-FMK,	or	a	pan-caspase	inhibitor,	Z-VAD-FMK	(Figure	4d-e).	




by cell autonomous and nonautonomous mechanisms.












was significantly decreased in the skin of Ercc1−/Δ mice	(at	4,	14,	and	
18	weeks	of	age)	compared	to	age-matched	wt	mice	(Figure	5b,c).	In	
addition,	 localization	 of	 the	 terminal	 differentiation	marker,	 loricrin,	
was abnormal in the skin of Ercc1−/Δ mice	at	18	weeks	of	age,	indicating	
a	disruption	in	normal	skin	structure,	possibly	due	to	depletion	of	stem	
cell	populations	(Figure	5d).	These	data	indicate	that	ERCC1	deficiency	
in the mouse skin results in cellular senescence followed by apoptosis 
and	suggest	that	stem	cell	depletion,	likely	through	apoptosis,	may	be	
a major cause of the premature skin aging in Ercc1−/Δ mice.
3  | DISCUSSION
Cellular senescence is a cell fate in which cells irreversibly arrest pro-
liferation,	in	part	as	a	defense	mechanism	against	damage	and	neo-





























Senescent	 cells	 are	 generally	 resistant	 to	 apoptosis,	 often	 due	
to	 increased	expression	of	anti-apoptotic	proteins	belonging	to	the	
BCL	family.	A	new	class	of	small	molecules,	termed	senolytics,	have	
now been developed that target these proteins to selectively alter the 
fate	of	senescent	cells,	causing	them	to	die	by	apoptosis	(Chang	et	al.,	
2016;	Yosef	et	al.,	2016).	Most	senescent	cells	resist	apoptotic	death,	
although senescent endothelial cells have been reported to undergo 
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a	 cell	 fate	 transition	 to	 apoptosis	 by	 reducing	 anti-apoptotic	 pro-
tein	levels	or	increasing	pro-apoptotic	protein	levels	(Li	et	al.,	2005;	
Matsushita	et	al.,	2001;	Zhang	et	al.,	2002).	Indeed,	we	determined	




in neighboring cells and in senescent cells themselves due to their 
defect	in	DNA	repair	(Figure	S2D).	However,	we	cannot	rule	out	the	
possibility that the results depend on the stage of senescent cells.
ERCC1 depletion in several cell types caused micronuclei forma-
tion,	which	was	 linked	 to	chromosome	mis-segregation	 (Melton	et	
al.,	1998;	Niedernhofer	et	al.,	2004).	Using	DAPI	 staining,	we	also	
observed	micronuclei	 in	ERCC1-deficient	 fibroblasts.	Although	we	
have	not	 tested	 this	 hypothesis	 directly,	 it	 is	 conceivable	 that	 the	
formation	 of	micronuclei	 and	 possibly	 cytosolic	 DNA	 triggers	 the	
cGAS-STING	pathway,	thereby	activating	NF-κB and elevating type 
I	IFN	signaling,	both	of	which	were	recently	shown	to	occur	in	senes-
cent	cells	(De	Cecco	et	al.,	2019).	Indeed,	Tilstra	et	al.	reported	that	
NF-κB activation was significantly enhanced in multiple tissues from 
Ercc1–/Δ	mice,	 including	 kidney,	 liver,	 pancreas,	 spleen	 and	muscle	
(Tilstra	et	al.,	2012).	In	addition,	it	was	reported	that	IFN-γ activates 




ERCC1	 participates	 in	 several,	 related	DNA	 repair	 processes,	 in-
cluding	NER,	TCR	and	interstrand	crosslinking	repair	(Dolle	et	al.,	2011;	
Weeda	et	al.,	1997).	Ercc1−/Δ mice are a model for human Cockayne and 
COF	syndromes,	which	are	rare	progeroid	syndromes	with	extremely	
short	lifespans	(Gregg	et	al.,	2011;	Vermeij,	Dollé,	et	al.,	2016).	Increases	





processes	 are	 induced,	presumably	 sequentially,	 by	ERCC1	depletion	
identifies a potential mechanism – namely that apoptosis is caused by a 
SASP	factor,	TNFα,	secreted	by	senescent	cells.	Yet,	this	TNFα secretion 
promotes	apoptosis	only	under	the	circumstances	where	DNA	repair	is	




driven	apoptosis.	It	has	been	shown	that	TNFα increases the proportion 
of	cells	entering	S	phase	and	thus	causes	replication	stress,	which	can	
result	 in	apoptosis	 in	NER-incompetent	premalignant	cells	(Faurschou	
et	 al.,	 2008).	Here,	 it	 is	 also	possible	 that	TNFα	 secreted	by	ERCC1-
depleted	senescent	cells	could	trigger	entry	into	S	phase,	and	thus	in-
duce	apoptosis	 in	DNA	repair-deficient	neighboring	cells.	 In	addition,	
TNFα secretion could induce apoptosis in a cell autonomous manner.
Recent findings show that caloric restriction can be an effective 






induced	 apoptosis,	 which	 could	 delay	 the	 accelerated	 aging	 pheno-
types	and	possibly	explain	the	extended	median	and	maximal	lifespans	
observed in calorie restricted Ercc1−/Δ	mice	(Vermeij,	Dollé,	et	al.,	2016).
Anti-TNFα therapy is approved to treat many inflammatory dis-
eases,	 including	rheumatoid	arthritis,	psoriasis	and	Crohn's	disease	
(Sedger	&	McDermott,	 2014).	 Blocking	 TNFα signaling effectively 
prevents	 the	 induction	 of	 inflammation	 mediators	 such	 as	 IL-6	
(Gupta,	2002).	Here,	we	suggest	a	novel	anti-TNFα therapeutic ap-
proach	to	prevent	apoptosis	by	TNFα	signaling.	Anti-TNFα therapy 
could present an alternative intervention in Ercc1−/Δ mice to counter-
act	aging	phenotypes,	such	as	those	in	the	skin,	although	anti-TNFα 
therapy	would	reduce	apoptosis	without	preventing	DNA	damage.
In	 4-week-old	 Ercc1−/Δ	 mice,	 which	 was	 the	 age	 at	 which	 we	
began	eliminating	senescent	cells,	 these	cells	already	accumulated	




nescent	 cells	 did	not	 affect	ERCC1	depletion-induced	phenotypes	




nescent cells in a timely fashion and replenishing stem cells might 
reduce	the	DNA	damage	response	(Ocampo	et	al.,	2016),	and	delay	








et	 al.,	 2016)	 as	 observed	 in	 Ercc1−/Δ	 mice.	 Unfortunately,	 the	 cur-
rent treatment for those patients is limited to symptomatic support 
(Wilson	et	al.,	2016).	Our	findings	suggest	a	novel	therapeutic	inter-
vention	for	long-term	health	benefits	in	these	patients,	namely	stem	
cell pool replenishment along with the clearance of senescent cells.
4  | E XPERIMENTAL PROCEDURES
4.1 | Cell cultures
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4.2 | Chemicals and treatments
The	 TNFα-blocking	 antibody	 was	 from	 Cell	 Signaling	 Technology,	
the	small	molecule	TNFα	 inhibitor	(SPD304),	which	interferes	with	
protein–protein interactions mediated by glycine 122 residues in 
the	 trimeric	 TNFα	 receptor	 type	 1	 (TNFR1),	 thereby	 dissociating	
the	 trimer	 and	 inhibiting	 TNFR1	 activity,	was	 from	Sigma-Aldrich,	
and	the	caspase	8	(Z-IETD-FMK)	and	pan-caspase	(Z-VAD-FMK)	in-
hibitors	were	 from	R&D	Systems.	Human	 fibroblasts	were	seeded	
and,	 the	next	day,	 infected	with	pLKO.1-ERCC1	or	 control	 lentivi-
ruses,	followed	by	treatment	every	other	day	with	100	ng/ml	TNFα-
blocking	 antibody,	 1	 μM	 SPD304,	 50	 μM	 Z-IETD-FMK	 or	 50	 μM	
Z-VAD-FMK,	together	with	vehicle	controls.
4.3 | Animals




were crossed to obtain Ercc1−/Δ offspring with a genetically uniform 
F1	C57BL6J/FVB	hybrid	background	 (Dolle	et	al.,	2011;	Weeda	et	
al.,	1997).	Typical	unfavorable	characteristics,	 such	as	blindness	 in	
the	 FVB	background	 or	 deafness	 in	 the	C57BL6J	 background,	 do	
not	occur	in	this	hybrid	background.	Since	Ercc1−/Δ	mice	are	smaller,	











4.4 | Genetic manipulations and gene 
expression analysis
Lentiviral	 vectors	 (pLKO.1-puro)	 encoding	 shRNAs	 against	 ERCC1	
were	purchased	from	Dharmacon.	pLKO.1-ERCC1	lentiviruses	were	
packaged	 in	 HEK293FT	 and	 supernatants	 were	 collected	 after	
48	hr.	Cells	were	infected	with	the	titrated	lentiviruses,	followed	by	
selection in 1 μg/ml	puromycin	for	3	days.	For	siRNA	experiments,	
cells	 were	 transfected	 with	 50	 pmole	 ERCC1	 siRNA	 (Santa	 Cruz	
Biotechnology)	using	Lipofectamine	2000	(Invitrogen)	for	8	hr,	as	per	
the	manufacturer's	recommendation.	Cells	were	collected	for	analy-






4.5 | SA-β-gal staining and EdU labeling




(Velarde,	Demaria,	Melov,	&	Campisi,	 2015;	Wiley	 et	 al.,	 2016).	A	
Nikon	 Eclipse	 E800	microscope	was	 used	 for	 imaging	 and	 images	
were	quantified	using	Image	J	software.
Cell proliferation was evaluated by incorporation of 
5-ethynyl-2′-deoxyuridine	 (EdU)	 and	 the	 Click-iT	 EdU	 Cell	
Proliferation	Assay	Kit	 (Invitrogen).	Briefly,	cells	were	given	10	μM	
EdU	 for	 24	 hr	 before	 fixation,	 permeabilized	 and	 incubated	 with	
Click-iT	reaction	cocktail	as	per	the	manufacturer's	 instructions.	A	
Zeiss	LSM780	confocal	microscope	was	used	 for	 imaging,	and	 im-
ages	were	quantified	using	 Image	 J	 software.	>100	cells	 from	5–7	
different	 fields	were	quantified	per	condition,	and	all	experiments	
were done in duplicate.
4.6 | Immunofluorescence staining
Human	cells	and	skin	cryosections	 (7–8	μm)	were	fixed	 in	4%	par-
aformaldehyde,	 permeabilized,	 blocked	 and	 immunostained	 as	
described	 (Davalos	 et	 al.,	 2013;	 Freund	 et	 al.,	 2012;	 Rodier	 et	 al.,	
2009).	 Primary	 antibodies	 were	 rabbit	 anti-ERCC1	 (Santa	 Cruz	
#sc-10785),	 rabbit	 anti-γH2AX	 (Novus	 #NB100-79967),	 rabbit	
anti-HMGB1	(Abcam	#ab18256),	goat	anti-LMNB1	(Santa	Cruz	#sc-
6217),	 rabbit	 anti-cleaved	 caspase	 3	 (Cell	 Signaling	 #9664),	 rabbit	
anti-p63	(GeneTex	#GTX102425),	chicken	anti-keratin14	(BioLegend	
#906001),	 rabbit	anti-Lgr6	 (Abcam	#ab126747),	 rabbit	anti-loricrin	
(Covance	#PRB-145P)	and	chicken	anti-vimentin	(Abcam	#ab24525).	
Secondary	antibodies	were	Alexa	Fluor	488	anti-mouse,	Alexa	Fluor	
488	 anti-goat,	 Alexa	 Fluor	 488	 anti-chicken	 and	 Alexa	 Fluor	 597	
anti-rabbit	IgG	from	Molecular	Probe.	A	Zeiss	LSM780	confocal	mi-








and detection using enhanced chemiluminescence. Primary anti-
bodies	were	rabbit	anti-ERCC1	 (Santa	Cruz	#sc-10785)	and	mouse	
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croscope was used for imaging and the images were quantified using 
Image	J	software.	At	least	three	different	fields	with	>300	cells	per	
field	were	quantified	per	condition,	and	tissues	from	three	different	
animals were used for the assay.
4.9 | TNFα ELISA
Cells	 were	 infected	 with	 lentivirus	 expressing	 ERCC1	 shRNA	 as	
well	 as	 a	 scrambled	 shRNA,	 and	 cultured	 for	 7	 days.	Conditioned	
media	were	collected	 from	cells	cultured	 in	0.2%	serum	for	24	hr,	









t-test	 (also	called	unequal	variances	 t-test),	a	modified	Student's	 t-
test	under	the	assumption	of	unequal	variances.	Most	of	cell	culture	
experiments	were	done	 in	 triplicate	and	reproduced	at	 least	 three	
times independently.
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